Dexcom (DXCM) EBIT Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.94% |
| Dec 31, 2025 | 25.44% |
| Sep 30, 2025 | 20.84% |
| Jun 30, 2025 | 25.68% |
| Mar 31, 2025 | 31.81% |
| Dec 31, 2024 | 13.23% |
| Sep 30, 2024 | 22.10% |
| Jun 30, 2024 | 188.40% |
| Mar 31, 2024 | 55.26% |
| Dec 31, 2023 | 27.11% |
| Sep 30, 2023 | 71.38% |
| Jun 30, 2023 | 94.93% |
| Mar 31, 2023 | 28.75% |
| Dec 31, 2022 | 59.89% |
| Sep 30, 2022 | 212.29% |
| Jun 30, 2022 | 50.27% |
| Mar 31, 2022 | 24.76% |
| Dec 31, 2021 | 15.98% |
| Sep 30, 2021 | 53.04% |
| Jun 30, 2021 | 47.68% |
| Mar 31, 2021 | 34.43% |
| Dec 31, 2020 | 130.45% |
| Sep 30, 2020 | 33.37% |
| Jun 30, 2020 | 83.55% |
| Mar 31, 2020 | 35.96% |
| Dec 31, 2019 | 129.33% |
| Sep 30, 2019 | 67.54% |
| Jun 30, 2019 | 32.71% |
| Mar 31, 2019 | -3.20% |
| Dec 31, 2018 | -134.93% |
| Sep 30, 2018 | 34.47% |
| Jun 30, 2018 | 13.12% |
| Mar 31, 2018 | -23.01% |
| Dec 31, 2017 | 28.07% |
| Sep 30, 2017 | 50.78% |
| Jun 30, 2017 | 1.54% |
| Mar 31, 2017 | -21.28% |
| Dec 31, 2016 | 12.99% |
| Sep 30, 2016 | -6.81% |
| Jun 30, 2016 | -22.16% |
| Mar 31, 2016 | -10.10% |
| Dec 31, 2015 | 16.67% |
| Sep 30, 2015 | -26.55% |
| Jun 30, 2015 | 20.40% |